News
Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ETCompany ParticipantsJostein Lovas - IRBijan Mossavar-Rahmani - ...
Explore why INmune Bio, Inc. is a speculative Strong Buy for high-risk investors. Click for the upcoming catalysts that make ...
Good afternoon, ladies and gentlemen, and welcome to the CAVA first-quarter 2025 earnings conference call. (Operator Instructions) This call is being recorded on May 15, 2025. I would now like to turn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback